Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

The Simian virus 40 late viral protein VP4 disrupts the nuclear envelope for viral release.

Giorda KM, Raghava S, Hebert DN.

J Virol. 2012 Mar;86(6):3180-92. doi: 10.1128/JVI.07047-11. Epub 2012 Jan 11.

2.

The SV40 late protein VP4 is a viroporin that forms pores to disrupt membranes for viral release.

Raghava S, Giorda KM, Romano FB, Heuck AP, Hebert DN.

PLoS Pathog. 2011 Jun;7(6):e1002116. doi: 10.1371/journal.ppat.1002116. Epub 2011 Jun 30.

3.

The Presumed Polyomavirus Viroporin VP4 of Simian Virus 40 or Human BK Polyomavirus Is Not Required for Viral Progeny Release.

Henriksen S, Hansen T, Bruun JA, Rinaldo CH.

J Virol. 2016 Oct 28;90(22):10398-10413. Print 2016 Nov 15.

4.

SV40 late protein VP4 forms toroidal pores to disrupt membranes for viral release.

Raghava S, Giorda KM, Romano FB, Heuck AP, Hebert DN.

Biochemistry. 2013 Jun 4;52(22):3939-48. doi: 10.1021/bi400036z. Epub 2013 May 20.

5.

A very late viral protein triggers the lytic release of SV40.

Daniels R, Sadowicz D, Hebert DN.

PLoS Pathog. 2007 Jul;3(7):e98.

6.

Simian virus 40 late proteins possess lytic properties that render them capable of permeabilizing cellular membranes.

Daniels R, Rusan NM, Wilbuer AK, Norkin LC, Wadsworth P, Hebert DN.

J Virol. 2006 Jul;80(13):6575-87.

7.

Patterns of polyomavirus SV40 infections and associated cancers in humans: a model.

Butel JS.

Curr Opin Virol. 2012 Aug;2(4):508-14. doi: 10.1016/j.coviro.2012.06.004. Epub 2012 Jul 6. Review.

9.

The human polyoma JC virus agnoprotein acts as a viroporin.

Suzuki T, Orba Y, Okada Y, Sunden Y, Kimura T, Tanaka S, Nagashima K, Hall WW, Sawa H.

PLoS Pathog. 2010 Mar 12;6(3):e1000801. doi: 10.1371/journal.ppat.1000801.

10.

Import of simian virus 40 virions through nuclear pore complexes.

Clever J, Yamada M, Kasamatsu H.

Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7333-7.

11.

Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease.

Lednicky JA, Arrington AS, Stewart AR, Dai XM, Wong C, Jafar S, Murphey-Corb M, Butel JS.

J Virol. 1998 May;72(5):3980-90.

12.

[Relationship between the malignant mesothelioma and simian virus 40 in China: a study of 17 cases].

Jin ML, Li X, Luo J, Zhao HY, Liu Y.

Zhonghua Bing Li Xue Za Zhi. 2006 Oct;35(10):602-5. Chinese.

PMID:
17134568
14.
15.

BK virus large T and VP-1 expression in infected human renal allografts.

Seemayer CA, Seemayer NH, Dürmüller U, Gudat F, Schaub S, Hirsch HH, Mihatsch MJ.

Nephrol Dial Transplant. 2008 Dec;23(12):3752-61. doi: 10.1093/ndt/gfn470. Epub 2008 Sep 9. Review.

16.

Cell and molecular biology of simian virus 40: implications for human infections and disease.

Butel JS, Lednicky JA.

J Natl Cancer Inst. 1999 Jan 20;91(2):119-34. Review.

PMID:
9923853
17.

Different susceptibility of human mesothelial cells to polyomavirus infection and malignant transformation.

Carbone M, Burck C, Rdzanek M, Rudzinski J, Cutrone R, Bocchetta M.

Cancer Res. 2003 Oct 1;63(19):6125-9.

18.

Detection of polyomavirus simian virus 40 tumor antigen DNA in AIDS-related systemic non-Hodgkin lymphoma.

Vilchez RA, Lednicky JA, Halvorson SJ, White ZS, Kozinetz CA, Butel JS.

J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):109-16.

PMID:
11832678
19.

Molecular identification of simian virus 40 infection in healthy Italian subjects by birth cohort.

Paracchini V, Garte S, Pedotti P, Poli F, Frison S, Taioli E.

Mol Med. 2005 Jan-Dec;11(1-12):48-51.

20.

Supplemental Content

Support Center